HealthEquity Total Assets 2014-2024 | HQY

HealthEquity total assets from 2014 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • HealthEquity total assets for the quarter ending October 31, 2024 were $3.488B, a 12.76% increase year-over-year.
  • HealthEquity total assets for 2024 were $3.164B, a 2.42% increase from 2023.
  • HealthEquity total assets for 2023 were $3.089B, a 0.59% decline from 2022.
  • HealthEquity total assets for 2022 were $3.107B, a 14.64% increase from 2021.
HealthEquity Annual Total Assets
(Millions of US $)
2024 $3,164
2023 $3,089
2022 $3,107
2021 $2,710
2020 $2,565
2019 $510
2018 $369
2017 $279
2016 $220
2015 $159
2014 $55
2013 $46
HealthEquity Quarterly Total Assets
(Millions of US $)
2024-10-31 $3,488
2024-07-31 $3,514
2024-04-30 $3,246
2024-01-31 $3,164
2023-10-31 $3,094
2023-07-31 $3,066
2023-04-30 $3,035
2023-01-31 $3,089
2022-10-31 $3,065
2022-07-31 $3,074
2022-04-30 $3,065
2022-01-31 $3,107
2021-10-31 $3,100
2021-07-31 $3,149
2021-04-30 $3,162
2021-01-31 $2,710
2020-10-31 $2,657
2020-07-31 $2,664
2020-04-30 $2,562
2020-01-31 $2,565
2019-10-31 $2,560
2019-07-31 $1,098
2019-04-30 $597
2019-01-31 $510
2018-10-31 $478
2018-07-31 $455
2018-04-30 $418
2018-01-31 $369
2017-10-31 $356
2017-07-31 $331
2017-04-30 $303
2017-01-31 $279
2016-10-31 $264
2016-07-31 $251
2016-04-30 $232
2016-01-31 $220
2015-10-31 $212
2015-07-31 $203
2015-04-30 $165
2015-01-31 $159
2014-10-31 $153
2014-07-31 $66
2014-04-30 $0
2014-01-31 $0
2013-10-31 $0
2013-07-31 $0
2013-01-31 $46
Sector Industry Market Cap Revenue
Medical Medical Services $9.429B $1.000B
HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $92.839B 12.14
Cencora (COR) United States $49.468B 18.60
DiDi Global (DIDIY) China $22.650B 0.00
Natera (NTRA) United States $22.209B 0.00
ICON (ICLR) Ireland $16.344B 14.56
Revvity (RVTY) United States $15.033B 26.11
Avantor (AVTR) United States $14.626B 21.93
BioMerieux (BMXMF) France $14.203B 0.00
Viatris (VTRS) United States $13.523B 4.17
CochLear (CHEOY) Australia $12.916B 0.00
Solventum (SOLV) United States $12.870B 0.00
Doximity (DOCS) United States $10.767B 63.37
Medpace Holdings (MEDP) United States $10.662B 30.04
EUROFINS SCIENT (ERFSF) Luxembourg $10.135B 0.00
Sonic Healthcare (SKHHY) Australia $8.657B 0.00
Charles River Laboratories (CRL) United States $8.266B 15.97
Bausch + Lomb (BLCO) Canada $6.301B 29.31
Amplifon S.p.A (AMFPF) Italy $6.136B 31.28
BrightSpring Health Services (BTSG) United States $4.136B 87.96
Organon (OGN) United States $4.079B 4.11
Sotera Health (SHC) United States $3.875B 20.73
Surgery Partners (SGRY) United States $3.273B 37.32
Concentras Parent (CON) United States $2.998B 0.00
Alignment Healthcare (ALHC) United States $2.937B 0.00
Premier (PINC) United States $2.191B 11.40
Ardent Health Partners (ARDT) United States $2.098B 0.00
PACS (PACS) United States $2.080B 0.00
GeneDx Holdings (WGS) United States $2.079B 0.00
Progyny (PGNY) United States $1.980B 40.09
GoodRx Holdings (GDRX) United States $1.845B 48.40
Teladoc Health (TDOC) United States $1.782B 0.00
Agilon Health (AGL) United States $1.413B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.409B 0.00
Pediatrix Medical (MD) United States $1.219B 11.92
CareDx (CDNA) United States $1.210B 0.00
Embecta (EMBC) United States $1.070B 7.48
AMN Healthcare Services Inc (AMN) United States $1.036B 7.02
Establishment Labs Holdings (ESTA) $0.947B 0.00
Auna S.A (AUNA) Luxembourg $0.637B 0.00
SBC Medicals (SBC) United States $0.518B 0.00
InnovAge Holding (INNV) United States $0.505B 0.00
DocGo (DCGO) United States $0.490B 18.46
QDM (QDMI) Hong Kong, SAR China $0.480B 12.56
Sonida Senior Living (SNDA) United States $0.451B 0.00
Enhabit (EHAB) United States $0.422B 36.52
COMPASS Pathways (CMPS) United Kingdom $0.280B 0.00
MultiPlan (MPLN) United States $0.267B 0.00
LifeMD (LFMD) United States $0.248B 0.00
Nutex Health (NUTX) United States $0.243B 0.00
Sera Prognostics (SERA) United States $0.212B 0.00
Beauty Health (SKIN) United States $0.205B 0.00
Performant Healthcare (PHLT) United States $0.184B 0.00
Biodesix (BDSX) United States $0.151B 0.00
So-Young (SY) China $0.105B 17.83
Ascend Wellness Holdings (AAWH) United States $0.079B 0.00
IceCure Medical (ICCM) Israel $0.068B 0.00
ModivCare (MODV) United States $0.066B 3.57
Oncology Institute (TOI) United States $0.063B 0.00
NeueHealth (NEUE) United States $0.061B 1.61
Singular Genomics Systems (OMIC) United States $0.050B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.038B 0.00
OncoCyte (OCX) United States $0.034B 0.00
Co-Diagnostics (CODX) United States $0.025B 0.00
Pheton Holdings (PTHL) China $0.024B 0.00
KindlyMD (KDLY) United States $0.008B 0.00
SeaStar Medical Holding (ICU) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
XWELL (XWEL) United States $0.007B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
ISpecimen (ISPC) United States $0.002B 0.00
Aclarion (ACON) United States $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00